Analyst Conference Summaries

Biotechnology Investor Aids

Syros Pharmaceuticals

conference date: May 7, 2020 @ 5:30 AM Pacific Time

Syros Pharmaceuticals Update: Still a Buy [January 23, 2020 at Seeking Alpha]

Syros Pharmaceuticals Platform Undervalued [April 10, 2019 at Seeking Alpha]

Q4 2019
Q1 2020
March 5, 2020 May 7, 2020    

Syros Pharmaceuticals (SYRS) is a clinical-stage biotechnology company with a platform based on gene regulation.

Syros Pharmaceutical web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2020 William P. Meyers